Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun;66(4):475-477.
doi: 10.1111/1754-9485.13421.

Immunotherapy, radiation oncology and radiology: An alliance into the future

Affiliations
Editorial

Immunotherapy, radiation oncology and radiology: An alliance into the future

Eric Hau et al. J Med Imaging Radiat Oncol. 2022 Jun.

Abstract

A/Prof Eric Hau is a clinician-scientist with interest in lung and CNS tumours. His clinical and laboratory research focuses on understanding the mechanisms of radiation resistance and investigating drugs which may be utilised for radiation sensitisation to improve outcomes for patients. Associate Professor Warren Clements is an Interventional Radiologist at Alfred Health and has an Adjunct appointment with the Department of Surgery, Central Clinical School, Monash University. A/Prof Clements completed post-fellowship subspecialty training in Interventional Radiology, consolidated by completion of the EBIR certification. A/Prof Clements is actively involved in medical research with over 80 peer-reviewed publications, and has presented his research at national and international conferences. He is an Associate Editor for JMIRO and editorial board member of both CVIR and CVIR Endovascular. He volunteers his time for RANZCR as a member of the Interventional Radiology Committee and as an editorial board member for RANZCR's Inside Radiology website. A/Prof Clements has a keen interest in education and training, and is the supervisor of Intern Training in the Radiology Department. Dr. Joseph (Joe) Sia is a Consultant Radiation Oncologist at the Peter MacCallum Cancer Centre, Melbourne, Australia. He obtained his medical degree from the University of Otago, New Zealand and completed his radiation oncology training in Melbourne in 2017. He then undertook a laboratory-based PhD in tumour immunology at the University of Melbourne, which was awarded in 2020.

PubMed Disclaimer

References

    1. Upadhaya S, Neftelinov ST, Hodge J, Campbell J. Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape. Nat Rev Drug Discov 2022. Epub ahead of print. https://doi.org/10.1038/d41573-022-00030-4
    1. Passaro A, Brahmer J, Antonia S, Mok T, Peters S. Managing resistance to immune checkpoint inhibitors in lung cancer: treatment and novel strategies. J Clin Oncol 2022; 40: 598-610.
    1. Sia J, Neeson PJ, Haynes NM. Basic cancer immunology for radiation oncologists. J Med Imaging Radiat Oncol 2022; 66: 508-18.
    1. Simon Davis DA, Atmosukarto II, Garrett J, Gosling K, Syed FM, Quah BJ. Irradiation immunity interactions. J Med Imaging Radiat Oncol 2022; 66: 519-35.
    1. Shanker MD, Garimall S, Gatt N et al. Stereotactic radiosurgery for melanoma brain metastases: concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes. J Med Imaging Radiat Oncol 2022; 66: 536-45.

Publication types

LinkOut - more resources